Eltroxin 25microgram tablets

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)

العنصر النشط:

Levothyroxine sodium anhydrous

متاح من:

Advanz Pharma

ATC رمز:

H03AA01

INN (الاسم الدولي):

Levothyroxine sodium anhydrous

جرعة:

25microgram

الشكل الصيدلاني:

Oral tablet

طريقة التعاطي:

Oral

الفئة:

No Controlled Drug Status

نوع الوصفة الطبية :

Valid as a prescribable product

ملخص المنتج:

BNF: 06020100; GTIN: 5021691110040

نشرة المعلومات

READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR
YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor,
pharmacist or nurse.
-
This medicine has been prescribed for you only. Do not
pass it on to others. It may harm them, even if their signs of
illness are the same as yours.
-
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed
in this leaflet. See section 4
WHAT IS IN THIS LEAFLET:
1.
WHAT ELTROXIN TABLETS ARE AND WHAT THEY ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE ELTROXIN TABLETS
3.
HOW TO TAKE ELTROXIN TABLETS
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE ELTROXIN TABLETS
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1. WHAT ELTROXIN TABLETS ARE AND
WHAT THEY ARE USED FOR
Thyroxine is a hormone which is produced naturally in the
body by the thyroid gland. Levothyroxine is a synthetic version
of this hormone. Thyroxine controls how much energy your
body uses. When the thyroid gland does not produce enough
thyroxine (a condition known as hypothyroidism), many of the
body’s functions slow down. Some of the most common
symptoms of hypothyroidism are:
• tiredness
• weight gain
• feeling depressed
Eltroxin tablets are used to replace the thyroxine that your
thyroid gland cannot produce and prevent the symptoms of
hypothyroidism. Before starting your treatment your doctor
will carry out a blood test to work out how much levothyroxine
you need.
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE ELTROXIN TABLETS
DO NOT TAKE ELTROXIN TABLETS
• if you are ALLERGIC to levothyroxine or any of the other
ingredients of this medicine (listed in section 6)
• if you suffer from an overactive thyroid gland that produces
too much thyroid hormone (thyrotoxicosis)
• if you have any condition that affects your adrenal glands
(your doctor will be able to advise you if you are not sure).
If any of these apply to you, do not take t

خصائص المنتج

OBJECT 1
ELTROXIN 25 MCG TABLETS
Summary of Product Characteristics Updated 29-May-2018 | Concordia
International - formerly AMCo
1. Name of the medicinal product
Eltroxin 25mcg tablets
Levothyroxine 25mcg tablets
2. Qualitative and quantitative composition
Each tablet contains 25 micrograms Levothyroxine sodium anhydrous.
Excipients with known effect
Lactose 30.49mg per tablet
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Tablet
Each tablet is engraved on one face with “LT” and 25 on the other.
4. Clinical particulars
4.1 Therapeutic indications
Recommended clinical indications: Control of hypothyroidism,
congenital hypothyroidism in infants,
acquired hypothyroidism in children and juvenile myxoedema.
4.2 Posology and method of administration
Posology
In younger patients, and in the absence of heart disease, a serum
Levothyroxine (T4) level of 70 to 160
nanomols per litre, or a serum thyrotrophin level of less than 5
milli-units per litre should be targeted. A
pre-therapy ECG is valuable because ECG changes due to hypothyroidism
may be confused with ECG
evidence of cardiac ischaemia. If too rapid an increase in metabolism
is produced (causing diarrhoea,
nervousness, rapid pulse, insomnia, tremors, and sometimes anginal
pain where there is latent cardiac
ischaemia,) dosage must be reduced, or withheld, for a day or two, and
then re-started at a lower dose
level.
Adults: Initially 50 to 100 micrograms daily (2 to 4 tablets daily),
preferably taken before breakfast or
your first meal of the day. Adjust at three to four week intervals by
50 micrograms until normal
metabolism is steadily maintained. The final daily dose may be up to
100 to 200 micrograms.
Elderly: As for patients aged over 50 years.
For patients over 50 years, initially, it is not advisable to exceed
50 micrograms daily. In this condition,
the daily dose may be increased by 50 micrograms at intervals of every
3-4 weeks, until stable thyroxine
levels are attained. The final daily dose may be up to 50 to 200
micrograms.
P